CORC  > 武汉大学
Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer
Wang, Hua-qing; Ren, Yangang; Qian, Zheng-zi; Fu, Kai; Zhang, Hui-lai; Li, Wei; Hou, Yun; Zhou, Shi-yong; Hao, Xi-shan; Xie, Cong-hua
刊名THORACIC CANCER
2012
卷号3期号:1
关键词Advanced non-small-cell lung cancer combined therapy nimotuzumab second-line chemotherapy
ISSN号1759-7706
DOI10.1111/j.1759-7714.2011.00083.x
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4049626
专题武汉大学
推荐引用方式
GB/T 7714
Wang, Hua-qing,Ren, Yangang,Qian, Zheng-zi,et al. Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer[J]. THORACIC CANCER,2012,3(1).
APA Wang, Hua-qing.,Ren, Yangang.,Qian, Zheng-zi.,Fu, Kai.,Zhang, Hui-lai.,...&Xie, Cong-hua.(2012).Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.THORACIC CANCER,3(1).
MLA Wang, Hua-qing,et al."Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer".THORACIC CANCER 3.1(2012).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace